EUVIMEDEUVIMED entdecken
Crossref

Investigation of Ghrelin Effects in Experimental Necrotizing Enterocolitis

Sabriye Korkut, Ahmet Özdemir iD, Sara Erol, Mahmut Güzel, Arzu Hanım Yay, Levent Korkmaz, Selim Kurtoğlu

American Journal of Perinatology · 01.04.2026 · 43 (06) · 800-806

DOI: 10.1055/a-2693-0478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2026. Verfasst von Sabriye Korkut und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, University of Health Sciences Faculty of Medicine, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Ghrelin. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was aimed to investigate the effects of exogenous ghrelin pretreatment in an experimental necrotizing enterocolitis (NEC) model. Neonatal rats were randomized into four groups: NEC, GH-NEC, Control, and GH-Control. Experimental NEC was induced in the NEC groups using hypoxia, hypothermia, and hyperosmolar formula. Ghrelin was administered intraperitoneally to the GH-NEC and GH-Control groups. Throughout the experiment, pups were monitored using clinical scoring. On day 4, they were sacrificed, followed by macroscopic scoring, and tissue samples were collected for histopathological and biochemical analysis. The NEC groups had significantly higher mean clinical, macroscopic, and histological scores compared with the control groups (p < 0.05). The GH-NEC group exhibited both a higher mean clinical score and a higher mean macroscopic score than the NEC group (p < 0.05). The mean survival time was significantly lower in the GH-NEC group compared with the NEC group (p = 0.003). However, histopathological scores and apoptotic cell counts were similar between the GH-NEC and NEC groups (p > 0.05). In this experimental NEC model, ghrelin pretreatment worsened clinical outcomes, negatively affected the macroscopic appearance of intestinal segments, and was associated with a decreased survival rate up to the time of sacrifice. Further studies are needed to determine the effects of ghrelin in experimental NEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterocolitis, NecrotizingGhrelinAnimalsRatsDisease Models, AnimalAnimals, NewbornRats, Sprague-DawleyApoptosisRandom Allocation

Substanzen

Ghrelin

Autor:innen und Institutionen

  • Department of Neonatology, University of Health Sciences Faculty of Medicine, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.
  • Department of Neonatology, University of Health Sciences Faculty of Medicine, Kayseri City Hospital, Kayseri, Türkiye.
  • Department of Neonatology, Yıldırım Bayezid Üniversity Faculty of Medicine, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Pediatric Surgery, Erciyes University Fakulty of Medicine, Kayseri, Türkiye.
  • Department of Histology and Embryology, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
  • Department of Neonatology, İstanbul Medipol University Faculty of Medicine, İstanbul, Türkiye.

ORCID-Profile: Ahmet Özdemir

Zitieren

APA

Korkut, S., Özdemir, A., Erol, S., Güzel, M., Yay, A. H., Korkmaz, L., & Kurtoğlu, S. (2026). Investigation of Ghrelin Effects in Experimental Necrotizing Enterocolitis. American Journal of Perinatology, 43(06), 800-806. https://doi.org/10.1055/a-2693-0478

Vancouver

Korkut S, Özdemir A, Erol S, Güzel M, Yay AH, Korkmaz L, et al. Investigation of Ghrelin Effects in Experimental Necrotizing Enterocolitis. American Journal of Perinatology. 2026;43(06):800-806. doi:10.1055/a-2693-0478

BibTeX
@article{Korkut2026,
  author = {Korkut, Sabriye and Özdemir, Ahmet and Erol, Sara and Güzel, Mahmut and Yay, Arzu Hanım and Korkmaz, Levent and Kurtoğlu, Selim},
  title = {Investigation of Ghrelin Effects in Experimental Necrotizing Enterocolitis},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {06},
  pages = {800--806},
  doi = {10.1055/a-2693-0478}
}
Kostenlos starten →